tradingkey.logo
tradingkey.logo
Search

Jaguar Health Inc

JAGX
Add to Watchlist
2.810USD
-0.230-7.57%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.05MMarket Cap
LossP/E TTM

TradingKey Stock Score of Jaguar Health Inc

Currency: USD Updated: 2026-07-02

Key Insights

Jaguar Health Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 131 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 16.00.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Jaguar Health Inc's Score

Industry at a Glance

Industry Ranking
131 / 157
Overall Ranking
484 / 4565
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Jaguar Health Inc Highlights

StrengthsRisks
Jaguar Health, Inc. is a commercial stage pharmaceuticals company. The Company is developing prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Its marketed drug Mytesi, (crofelemer 125 mg delayed-release tablets), is a first-in-class oral botanical drug product approved by the FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Its Canalevia-CA1, crofelemer delayed-release tablets drug, is an oral plant-based prescription product that is FDA conditionally approved to treat chemotherapy-induced diarrhea in dogs. It has an exclusive distribution agreement for the sale of Gelclair. It is developing a pipeline of prescription drug product candidates to address unmet needs in gastrointestinal health.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.93% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 11.51M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 11.51M.
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.98K shares, decreasing 12.98% quarter-over-quarter.

Analyst Rating

Based on 0 analysts
--
Current Rating
16.000
Target Price
+2527.26%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Jaguar Health Inc?

The TradingKey Stock Score provides a comprehensive assessment of Jaguar Health Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Jaguar Health Inc’s performance and outlook.

How do we generate the financial health score of Jaguar Health Inc?

To generate the financial health score of Jaguar Health Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Jaguar Health Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Jaguar Health Inc.

How do we generate the company valuation score of Jaguar Health Inc?

To generate the company valuation score of Jaguar Health Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Jaguar Health Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Jaguar Health Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Jaguar Health Inc.

How do we generate the earnings forecast score of Jaguar Health Inc?

To calculate the earnings forecast score of Jaguar Health Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Jaguar Health Inc’s future.

How do we generate the price momentum score of Jaguar Health Inc?

When generating the price momentum score for Jaguar Health Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Jaguar Health Inc’s prices. A higher score indicates a more stable short-term price trend for Jaguar Health Inc.

How do we generate the institutional confidence score of Jaguar Health Inc?

To generate the institutional confidence score of Jaguar Health Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Jaguar Health Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Jaguar Health Inc.

How do we generate the risk management score of Jaguar Health Inc?

To assess the risk management score of Jaguar Health Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Jaguar Health Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Jaguar Health Inc.